TY - JOUR
T1 - Development of severe bronchopulmonary dysplasia is associated with alterations in fecal volatile organic compounds
AU - Berkhout, Daniel J. C.
AU - Niemarkt, Hendrik J.
AU - Benninga, Marc A.
AU - Budding, Andries E.
AU - van Kaam, Anton H.
AU - Kramer, Boris W.
AU - Pantophlet, Charlene M.
AU - van Weissenbruch, Mirjam M.
AU - de Boer, Nanne K. H.
AU - de Meij, Tim G. J.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - BACKGROUND: The aim of this study was to evaluate the potential of fecal volatile organic compounds (VOCs), obtained by means of an electronic nose device (Cyranose 320), as early non-invasive biomarker for BPD. METHODS: In this nested case-control study performed at three Neonatal Intensive Care Units, fecal samples obtained at postnatal age of 7, 14, 21, and 28 days from preterm infants with severe bronchopulmonary dysplasia (BPD) were compared with fecal VOC profiles from matched controls. Microbiota analysis was performed by means of IS-pro technique on fecal samples collected at 28 days postnatally. RESULTS: VOC profiles of infants developing severe BPD (n = 15) could be discriminated from matched controls (n = 15) at postnatal age of 14 days (area under the curve (+/- 95% confidence interval), P-value, sensitivity, specificity; 0.72 (0.54-0.90), 0.040, 60.0%, 73.3%), 21 days (0.71 (0.52-0.90), 0.049, 66.7%, 73.3%) and 28 days (0.77 (0.59-0.96), 0.017, 69.2%, 69.2%) but not at 7 days. Intestinal microbiota did not differ between BPD subjects and controls. CONCLUSION: Fecal VOC profiles of infants developing BPD could be differentiated from controls at postnatal day 14, 21, and 28. VOC differences could not be directed to intestinal microbiota alterations but presumably reflect local and systemic metabolic and inflammatory pathways associated with BPD.
AB - BACKGROUND: The aim of this study was to evaluate the potential of fecal volatile organic compounds (VOCs), obtained by means of an electronic nose device (Cyranose 320), as early non-invasive biomarker for BPD. METHODS: In this nested case-control study performed at three Neonatal Intensive Care Units, fecal samples obtained at postnatal age of 7, 14, 21, and 28 days from preterm infants with severe bronchopulmonary dysplasia (BPD) were compared with fecal VOC profiles from matched controls. Microbiota analysis was performed by means of IS-pro technique on fecal samples collected at 28 days postnatally. RESULTS: VOC profiles of infants developing severe BPD (n = 15) could be discriminated from matched controls (n = 15) at postnatal age of 14 days (area under the curve (+/- 95% confidence interval), P-value, sensitivity, specificity; 0.72 (0.54-0.90), 0.040, 60.0%, 73.3%), 21 days (0.71 (0.52-0.90), 0.049, 66.7%, 73.3%) and 28 days (0.77 (0.59-0.96), 0.017, 69.2%, 69.2%) but not at 7 days. Intestinal microbiota did not differ between BPD subjects and controls. CONCLUSION: Fecal VOC profiles of infants developing BPD could be differentiated from controls at postnatal day 14, 21, and 28. VOC differences could not be directed to intestinal microbiota alterations but presumably reflect local and systemic metabolic and inflammatory pathways associated with BPD.
KW - GUT-LUNG AXIS
KW - INTESTINAL MICROBIOTA
KW - PREMATURE-INFANTS
KW - HEALTHY-CHILDREN
KW - ELECTRONIC NOSE
KW - PRETERM INFANTS
KW - DISEASE
KW - MORTALITY
KW - RISK
U2 - 10.1038/pr.2017.268
DO - 10.1038/pr.2017.268
M3 - Article
C2 - 29053703
SN - 0031-3998
VL - 83
SP - 412
EP - 419
JO - Pediatric Research
JF - Pediatric Research
IS - 2
ER -